{"id":"W2133353215","doi":"10.1517/14656566.7.2.177","title":"A review of erlotinib and its clinical use","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Medicine; Rash; Epidermal growth factor receptor; Gemcitabine; Clinical trial; Oncology; Erlotinib Hydrochloride; Internal medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Pancreatic cancer; Pharmacology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002121557,0.000376322,0.001899012,0.0001294723,0.00003929861,0.00001133013,0.00008864129,0.0001668847,0.0003635983],"category_scores_gemma":[0.00003935507,0.0002504717,0.0006012141,0.0001952268,0.00004738265,0.00006369012,0.00001503779,0.0002655719,0.0000305483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007599964,"about_ca_system_score_gemma":0.0003351844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001853291,"about_ca_topic_score_gemma":1.547086e-7,"domain_scores_codex":[0.9979222,0.0002208699,0.001011522,0.0004429122,0.0002265584,0.0001759231],"domain_scores_gemma":[0.9986756,0.0002892086,0.0004675559,0.000304149,0.0001018934,0.0001616157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003713442,0.0004428057,0.000005377713,0.02810002,0.0005297773,0.000005806791,0.00002246442,1.072118e-8,0.000001503224,0.00007791656,0.1115757,0.8592014],"study_design_scores_gemma":[0.001654351,0.0003343345,0.000005395822,0.1354438,0.0002605537,0.00003508212,9.410353e-7,0.00000169534,0.000008186345,0.000001104547,0.8620838,0.0001707424],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001267673,0.9955993,0.0000044511,0.0004016874,0.000872801,0.002306459,0.0001238139,0.00004664994,0.0006436288],"genre_scores_gemma":[3.277802e-7,0.990916,0.0002200983,0.006444914,0.0007673575,0.0003017855,0.0003906126,0.00008100948,0.0008779232],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8590307,"threshold_uncertainty_score":0.9999948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2225099471447932,"score_gpt":0.5773877545529791,"score_spread":0.3548778074081859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}